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ABSTRACT 
 
There are an increasing number of irradiated prostate-cancer survivors in the world 
today. For many of these men survival comes at a cost: unwanted debilitating side 
effects due to exposure of healthy normal tissue to ionizing radiation. Identifying 
clinical and dosimetric factors associated with these long-lasting side effects could 
provide a way of attaining the ultimate goal – curing prostate cancer with 
radiotherapy while restoring physical and psychological health for the prostate-cancer 
survivor.  
Following a preparatory qualitative phase, we constructed a study-specific 
questionnaire. In addition, we conducted a pilot study to evaluate the variation in 
position and volume of the organs at risk in the small pelvis. We received filled-in 
questionnaires from 874/985 (89%) prostate-cancer survivors and from 243/332 
(73%) population-based controls. We found that prostate-cancer survivors who 
smoked had an increased risk of long-lasting defecation urgency, diarrhea, the 
sensation of bowel not completely emptied after defecation and sudden emptying of 
all stools into clothing without forewarning compared to never smokers. We also 
found that men with loose stools and abdominal distension at least once a week had 
a higher prevalence of several long-lasting symptoms, such as defecation urgency, 
fecal leakage and sudden emptying of all stools into clothing compared to those with 
regular stools. Prostate-cancer survivors with abdominal distension at least once a 
week had an increased prevalence of unexpected passing of gas compared to those 
with regular stools. Finally, our data showed that mean absorbed dose of ionizing 
radiation to the anal-sphincter region of more than 40 Gy causes an increased 
occurrence of fecal leakage among irradiated prostate-caner survivors. 
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